A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
Part of paid clinical trials in Glendale, California.
- Sponsor
- Teligene US
- Study ID
- NCT06010329
- Phase
- PHASE2
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Sutetinib Maleate Capsule — DRUGOral administration
Study Details
The main objective of the study will be to evaluate the efficacy of sutetinib maleate capsules in participants with locally advanced or metastatic non-small cell lung cancer NSCLC (uncommon EGFR mutations only).
Key Dates
- Start date
- Dec 27, 2023
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 66 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Single arm, Open labelParticipants will receive sutetinib maleate capsule taken orally with (preferred) or without food, at the dose directed by the Investigators, 28 days for a cycle.
Primary Outcome Measure
Objective Response Rate (ORR) [ Time Frame: Pre-dose up to approximately 32 months post-dose ]
Central Contacts
- Xiaoyang Xia805-300-9373
- Dawei Zhang805-300-1019
Locations (9)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Oncology Physicians Network Healthcare | Glendale | California | 91203 | - |
| University of California San Diego Moores Cancer Center | La Jolla | California | 92093 | - |
| Moffitt Cancer Center | Tampa | Florida | 33612 | - |
| University Cancer & Blood Center (UCBC) - Athens | Athens | Georgia | 30607 | - |
| Mission Cancer + Blood - Mission Cancer Foundation | Des Moines | Iowa | 50309 | - |
| Norton Cancer Institute - Downtown | Louisville | Kentucky | 40202 | - |
| Northwell Health | New Hyde Park | New York | 11042 | - |
| Perlmutter Cancer Center - 34th Street | New York | New York | 10016 | - |
| University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | - |
Find similar trials in Glendale, CA
By condition
By specialty
By research site
Oncology Physicians Network Healthcare· Glendale, CAUniversity of California San Diego Moores Cancer Center· La Jolla, CAMoffitt Cancer Center· Tampa, FLUniversity Cancer & Blood Center (UCBC) - Athens· Athens, GAMission Cancer + Blood - Mission Cancer Foundation· Des Moines, IANorton Cancer Institute - Downtown· Louisville, KY
Related Studies
- Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL ActivityPHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung CancerPHASE3 · Recruiting · University of Texas Southwestern Medical Center · La Jolla, California
- VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaPHASE1/PHASE2 · Recruiting · VM Oncology, LLC · Santa Rosa, California
- Biomarkers for Risk Stratification in Lung CancerRecruiting · University of California, San Francisco · San Francisco, California